Strengthening Families & Communities LLC Buys 312 Shares of Medtronic PLC $MDT

Strengthening Families & Communities LLC grew its stake in shares of Medtronic PLC (NYSE:MDT) by 1.3% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 24,518 shares of the medical technology company’s stock after acquiring an additional 312 shares during the quarter. Medtronic comprises about 1.2% of Strengthening Families & Communities LLC’s portfolio, making the stock its 27th biggest holding. Strengthening Families & Communities LLC’s holdings in Medtronic were worth $2,145,000 as of its most recent filing with the SEC.

Other institutional investors have also recently modified their holdings of the company. 1248 Management LLC bought a new stake in shares of Medtronic during the 1st quarter valued at $26,000. Columbia River Financial Group LLC bought a new stake in shares of Medtronic during the 1st quarter valued at $28,000. Twin Tree Management LP bought a new stake in shares of Medtronic during the 1st quarter valued at $29,000. Activest Wealth Management lifted its position in shares of Medtronic by 3,577.8% during the 1st quarter. Activest Wealth Management now owns 331 shares of the medical technology company’s stock valued at $30,000 after acquiring an additional 322 shares during the period. Finally, Hughes Financial Services LLC bought a new stake in shares of Medtronic during the 1st quarter worth $32,000. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on MDT shares. Leerink Partners started coverage on Medtronic in a research report on Monday, June 16th. They set an “outperform” rating and a $110.00 price objective for the company. BTIG Research restated a “neutral” rating on shares of Medtronic in a research report on Friday, July 11th. Evercore ISI upped their price objective on Medtronic from $103.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 8th. Truist Financial upped their price objective on Medtronic from $92.00 to $96.00 and gave the stock a “hold” rating in a research report on Thursday, August 21st. Finally, The Goldman Sachs Group dropped their price objective on Medtronic from $82.00 to $81.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Medtronic has a consensus rating of “Moderate Buy” and a consensus price target of $102.41.

Medtronic Price Performance

Medtronic stock opened at $95.52 on Friday. The company has a current ratio of 2.01, a quick ratio of 1.50 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $122.52 billion, a PE ratio of 26.31, a P/E/G ratio of 2.54 and a beta of 0.78. Medtronic PLC has a 12 month low of $79.29 and a 12 month high of $99.37. The stock has a 50-day moving average price of $93.56 and a two-hundred day moving average price of $88.74.

Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, August 19th. The medical technology company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.23 by $0.03. The firm had revenue of $8.58 billion during the quarter, compared to the consensus estimate of $8.37 billion. Medtronic had a return on equity of 14.61% and a net margin of 13.63%.The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the company earned $1.23 earnings per share. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Analysts expect that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Friday, September 26th will be given a $0.71 dividend. The ex-dividend date is Friday, September 26th. This represents a $2.84 annualized dividend and a yield of 3.0%. Medtronic’s dividend payout ratio (DPR) is currently 78.24%.

Insider Activity

In other news, EVP Harry Skip Kiil sold 8,605 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $91.58, for a total value of $788,045.90. Following the completion of the sale, the executive vice president owned 35,615 shares of the company’s stock, valued at approximately $3,261,621.70. This represents a 19.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William R. Jellison purchased 2,500 shares of the firm’s stock in a transaction dated Monday, August 25th. The stock was bought at an average cost of $92.37 per share, with a total value of $230,925.00. Following the purchase, the director owned 5,000 shares of the company’s stock, valued at approximately $461,850. This trade represents a 100.00% increase in their position. The disclosure for this purchase can be found here. 0.26% of the stock is currently owned by company insiders.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.